BridgeBio Soars After FDA OKs Rival To Pfizer's Heart Drug - Investor's Business Daily

BridgeBio Pharma (BBIO) snagged Food and Drug Administration approval for a rival to Pfizer's (PFE) blockbuster heart drug, and BridgeBio stock catapulted by double digits.
XNOW PLAYINGBiotech Stock… [+3297 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
German steel giant ThyssenKrupp to slash 11,000 jobs - DW (English)
Right-Wingers Are Fantasizing About Elon Musk Buying MSNBC - Rolling Stone

Charlotte Douglas airport workers vote to strike - WSOC Charlotte
How S&P 500 tends to perform during Thanksgiving week and into New Year’s Eve - MarketWatch